- 专利标题： COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR
-
申请号： US17991482申请日： 2022-11-21
-
公开(公告)号： US20230226040A1公开(公告)日： 2023-07-20
- 发明人: Alejandro Amador Arjona , Angela Abdollahi , Margaret Favata , Jonathan Rios-Doria , Hui Wang , Susan Wee , Pei Gan , Jeffrey C. Yang , Yong Li , Le Zhao , Chunhong He , Chunyin Marshall Law , Wenyu Zhu , Xiaozhao Wang , Wenqing Yao , Peter Niels Carlsen , Fenglei Zhang , Qinda Ye , Matthew S. McCammant , Rocco Policarpo , Artem Shvartsbart , Jeremy Roach , Gia Hoang , Bin Hu , Gencheng Li , Robert Susick , Padmaja Polam , Chao Qi , Alexander Sokolsky , Haolin Yin , Chang Min
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation
- 当前专利权人： Incyte Corporation
- 当前专利权人地址： US DE Wilmington
- 主分类号： A61K31/4745
- IPC分类号： A61K31/4745 ; A61P35/00 ; A61P11/00 ; A61K31/5377 ; A61K31/519 ; A61K31/498 ; A61K31/506 ; A61K45/06
摘要：
The present disclosure relates to methods of treating cancer by administering a compound, which is a Fibroblast Growth Factor Receptor (FGFR) inhibitor, in combination with a Kirsten rat sarcoma (KRAS) inhibitor.
信息查询
IPC分类:
